P&G Hygiene Q1 profit slides 34% YoY to ₹126 Cr as margins compress on input, ad costs

P&G Hygiene & Health Care opened FY27 with a soft print: standalone revenue from operations fell 4.9% YoY to ₹891.46 Cr and net profit dropped 34.3% to ₹126.27 Cr (EPS ₹38.90 vs ₹59.17). Sequentially too the quarter softened — revenue −5.3% and PAT −17.5% versus Q4 FY26. The bottom line, not the topline, is the story: net margin compressed to 14.2% from 20.3% a year ago and 16.1% last quarter, and PBT fell a steeper 35.9% to ₹169.63 Cr.

The squeeze sits on two lines. Cost of raw and packing materials consumed jumped 21.8% YoY to ₹200.24 Cr and advertising & sales-promotion spend rose 21.2% to ₹83.32 Cr — the company kept investing behind its brands even as the topline contracted, while employee costs added another 12.4%. A partial offset came from an inventory build-up (₹33.22 Cr credit) and a modest 4.3% dip in other expenses, but neither was enough to protect the margin. Part of the optical severity is base: the year-ago June quarter was an unusually strong one in which PAT had doubled to ₹192 Cr, so this quarter's decline flatters the year-ago comparison rather than signalling a fresh collapse — the ₹126 Cr print still sits above pre-spike Q1 levels.

The stock went into the print at ₹8,780, down 3.3% over the past month of trading.

The result lands against a backdrop where brokerages had already flagged margin pressure into the quarter and trimmed earnings estimates; there is no published Q1 FY27 consensus figure to grade against, and the company gives no formal guidance. On the corporate side, the board's ₹60 final dividend for FY26 (record date Aug 26) and the 62nd AGM slated for Sep 2 proceed as scheduled, and a new sales head (Gopalakrishnan) took charge from July 1 — a leadership change that coincides with the demand and margin softness. The read into Q2 is whether input-cost inflation eases and whether the elevated brand spend starts to revive a topline that has now slipped both YoY and QoQ.